Locations:
Search IconSearch

Cancer

22-CNR-3423058-CQD-Hero-650×450 Dr Moore
December 20, 2022/Cancer/Research

Stopping Hormone Therapy for Pregnancy in Patients with Hormone-Receptor Positive Breast Cancer

First prospective study looks at endocrine therapy interruption in premenopausal patients

Lab research
December 16, 2022/Cancer/Research

Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors

Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia

22-DDI-3242262 – Neuroendocrine Tumor-Kim-3-hero
December 15, 2022/Cancer

Neuroendocrine Tumors: Today’s GIs Likely Will Encounter Them

Cleveland Clinic program to streamline clinical care and research

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Brian T. Hill
December 14, 2022/Cancer/Research

Precision Medicine Approach Needed to Treat Subgroups of Diffuse Large B-Cell Lymphoma

Distinct molecular features found in five subtypes of disease

CAR T-cells
December 13, 2022/Cancer/Research

Study Provides Insights about Chemorefractory Diffuse Large B-Cell Lymphoma

Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy

22-CNR-3405917-CQD-Hero-650×450 blood clot
December 12, 2022/Cancer/Research

Study Finds Biomarkers of Complications in Patients with Cancer Diagnosed with COVID-19

Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death

22-CNR-3344410-CQD-Hero-650×450 Dr Gerds Momentum trial
December 9, 2022/Cancer/Research

Sustained Response Observed in MOMENTUM Trial of Patients with Myelofibrosis

Study matches momelotinib against danazol

Labbous, MD
December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

whipple procedure
November 30, 2022/Cancer

Case Study: Patient Undergoing Whipple After Liver Transplant

Atypical cells discovered after primary sclerosing cholangitis diagnosis

BackPage 24 of 112Next

Advertisement

Ad